aTYR PHARMA INC
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 10240 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
Mailing Address 10240 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
Phone 8587318389
Fiscal Year End 1231
EIN 203435077
Financial Overview
FY2024
-$45.34M
Net Income
$120.65M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 6, 2025 | View on SEC |
| 4 Insider stock transaction report | October 9, 2025 | View on SEC |
Material Events
8-K Financial Distress December 5, 2025
High Impact
- aTYR PHARMA INC received a deficiency notice from Nasdaq for failing to maintain a minimum bid price of $1.00 per share.
- The company's stock price closed below $1.00 for 30 consecutive business days, violating Nasdaq's listing requirements.
Insider Trading
SELL 3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
PALISADE BIO, INC.
PALI Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.